Literature DB >> 16401990

Long-term survival cases of lung cancer presented as solitary bone metastasis.

Yasumitsu Hirano1, Makoto Oda, Yoshio Tsunezuka, Norihiko Ishikawa, Go Watanabe.   

Abstract

The prognosis of non-small cell lung carcinoma (NSCLC) with bone metastasis has been regarded as very poor. We report herein on two cases of NSCLC which presented as a solitary bone metastasis, were treated with surgical resection. Both these cases survived for over 5 years after their last operations. A 71-year-old-man was hospitalized with right crural pain. A diagnosis of squamous cell carcinoma of the left lower lobe with right fibula metastasis was made. A marginal resection of the right fibula was performed. After that, a left lower lobe lobectomy and systemic chemotherapy were carried out. He had a local recurrence in the right mediastinal lymph nodes eleven months after the operation. He received intraluminal and external radiation therapy and obtained complete remission. He has survived for 5 years without any other recurrence or metastasis. A 52-year-old-man was admitted to our hospital with left thigh pain. A diagnosis of adenocarcinoma of the right upper lobe with left thigh metastasis was made. A right upper lobe lobectomy and a resection of the left thigh tumor were performed. Three cycles of systemic chemotherapy were given after that. He has survived for 5 years since his last operation without any recurrence or metastasis.

Entities:  

Mesh:

Year:  2005        PMID: 16401990

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  20 in total

1.  Prolonged response to gefitinib in bone metastasis.

Authors:  Hiroaki Satoh; Hiroichi Ishikawa; Gen Ohara; Norihiro Kikuchi; Kiyohisa Sekizawa
Journal:  Med Oncol       Date:  2008-07-08       Impact factor: 3.064

2.  Surgical treatment of bone metastases in patients with lung cancer.

Authors:  Sandra Utzschneider; Ewa Wicherek; Patrick Weber; Gerwin Schmidt; Volkmar Jansson; Hans Roland Dürr
Journal:  Int Orthop       Date:  2010-06-18       Impact factor: 3.075

3.  Role of surgical intervention in managing gastrointestinal metastases from lung cancer.

Authors:  Po-Chu Lee; Chiao Lo; Ming-Tsan Lin; Jin-Tung Liang; Been-Ren Lin
Journal:  World J Gastroenterol       Date:  2011-10-14       Impact factor: 5.742

4.  Effect of synchronous solitary bone metastasectomy and lung cancer resection on non-small cell lung cancer patients.

Authors:  Tiancheng Zhao; Zongli Gao; Weiming Wu; Weiwei He; Y I Yang
Journal:  Oncol Lett       Date:  2016-02-08       Impact factor: 2.967

5.  Gastrointestinal metastasis of lung cancer with special emphasis on a long-term survivor after operation.

Authors:  Min Soo Kim; Eun Hee Kook; Se Han Ahn; Se Young Jeon; Jung Ho Yoon; Min Sung Han; Cheol Hyeon Kim; Jae Cheol Lee
Journal:  J Cancer Res Clin Oncol       Date:  2008-05-30       Impact factor: 4.553

6.  Predictors of survival in patients with bone metastasis of lung cancer.

Authors:  Hideshi Sugiura; Kenji Yamada; Takahiko Sugiura; Toyoaki Hida; Tetsuya Mitsudomi
Journal:  Clin Orthop Relat Res       Date:  2008-01-03       Impact factor: 4.176

7.  Surgery for skeletal metastases in lung cancer.

Authors:  Rudiger J Weiss; Rikard Wedin
Journal:  Acta Orthop       Date:  2011-02-01       Impact factor: 3.717

8.  Solitary metastasis of gastric cancer to fibula: a case report.

Authors:  Sepideh Hekmat; Tahereh Ghaedian; Hossein Barati; Mansour Movahed
Journal:  Iran J Radiol       Date:  2012-09-17       Impact factor: 0.212

9.  Detection of rib metastases in patients with lung cancer: a comparative study of MRI, CT and bone scintigraphy.

Authors:  Yan-Qing Chen; Yang Yang; Yan-Fen Xing; Sen Jiang; Xi-Wen Sun
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

Review 10.  Lung adenocarcinoma presenting as obstructive jaundice: a case report and review of literature.

Authors:  Stephanos Pericleous; Samrat Mukherjee; Robert R Hutchins
Journal:  World J Surg Oncol       Date:  2008-11-11       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.